PIK3CB and cancer: One of the most common events in human cancer is hyperactivation of the phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway, generally described as a consequence of genetic alterations of pathway members.